Menu

1 / 3

PepGen Inc. (PEPG) Discusses FREEDOM2 Lowest Dose Cohort Safety, Splicing And VHOT Results Transcript

All Articles on Seeking Alpha·about 8 hours ago
#NOibYNcq
#seekingalpha#research#division#call#pepgen
Long article (304 words) — no AI summary yet.
Reading 0:00
15s threshold

PepGen Inc. ( PEPG ) FREEDOM2 Lowest Dose Cohort Safety, Splicing and vHOT Conference November 10, 2026 8:00 AM ET

Company Participants

James G. McArthur - President, CEO, Treasurer, Secretary & Director

Paul D. Streck - Executive VP and Head of Research & Development

Johanna Hamel - Associate Professor of Neurology, Pathology and Laboratory Medicine, University of Rochester

Laurence Watts - IR

Conference Call Participants

Adam Tyler Vogel - Craig-Hallum Capital Group LLC, Research Division

Ananda Kumar Ghosh - H.C. Wainwright & Co, LLC, Research Division

Debjit D. Chattopadhyay - Guggenheim Securities, LLC, Research Division

Joseph Patrick Schwartz - Leerink Partners LLC, Research Division

Konstantinos Biliouris - Oppenheimer & Co.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.